🇺🇸 FDA
Patent

US 9096637

Organic compositions to treat HSF1-related diseases

granted A61KA61K31/713A61K45/06

Quick answer

US patent 9096637 (Organic compositions to treat HSF1-related diseases) held by Arrowhead Research Corporation expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arrowhead Research Corporation
Grant date
Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/713, A61K45/06, A61P, A61P19/02